Journal of Vascular and Interventional Radiology, 31(10), 1600-1608. Elsevier Inc. van Veldhuisen, E, Vroomen, L G, Ruarus, A H, Derksen, T C, Busch, O R, de Jong, M C, Kazemier, G, Puijk, R S, Sorgedrager, N S, Vogel, J A, Scheffer, H J, van Lienden, K P, Wilmink, J W, Besselink, M G & Meijerink, M R 2020, ' Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison ', Journal of Vascular and Interventional Radiology, vol. 31, no. 10, pp. 1600-1608 . https://doi.org/10.1016/j.jvir.2020.02.024 Journal of vascular and interventional radiology, 31(10), 1600-1608. Elsevier Inc.
Agnass, P, van Veldhuisen, E, van Gemert, M J C, van der Geld, C W M, van Lienden, K P, van Gulik, T M, Meijerink, M R, Besselink, M G, Kok, H P & Crezee, J 2020, ' Mathematical modeling of the thermal effects of irreversible electroporation for in vitro, in vivo, and clinical use : a systematic review ', International journal of hyperthermia, vol. 37, no. 1, pp. 486-505 . https://doi.org/10.1080/02656736.2020.1753828 International Journal of Hyperthermia, Vol 37, Iss 1, Pp 486-505 (2020)
Journal of vascular and interventional radiology, 33(7), 805-813.e1. Elsevier Inc. Journal of Vascular and Interventional Radiology, 33(7), 805-813.e1. Elsevier Inc. Franken, L C, van Veldhuisen, E, Ruarus, A H, Coelen, R J S, Roos, E, van Delden, O M, Besselink, M G, Klümpen, H-J, van Lienden, K P, van Gulik, T M, Meijerink, M R & Erdmann, J I 2022, ' Outcomes of Irreversible Electroporation for Perihilar Cholangiocarcinoma : A Prospective Pilot Study ', Journal of Vascular and Interventional Radiology, vol. 33, no. 7, pp. 805-813.e1 . https://doi.org/10.1016/j.jvir.2022.03.024
Journal of the National Cancer Institute, 111(8), 782-794. Oxford University Press Journal of the National Cancer Institute, 111(8):djz073, 782-794. Oxford University Press J Natl Cancer Inst
JAMA Oncology, 6(11), 1733-1740. American Medical Association JAMA Oncol van Roessel, S, van Veldhuisen, E, Klompmaker, S, Janssen, Q P, Abu Hilal, M, Alseidi, A, Balduzzi, A, Balzano, G, Bassi, C, Berrevoet, F, Bonds, M, Busch, O R, Butturini, G, Del Chiaro, M, Conlon, K C, Falconi, M, Frigerio, I, Fusai, G K, Gagnière, J, Griffin, O, Hackert, T, Halimi, A, Klaiber, U, Labori, K J, Malleo, G, Marino, M V, Mortensen, M B, Nikov, A, Lesurtel, M, Keck, T, Kleeff, J, Pandé, R, Pfeiffer, P, Pietrasz, D, Roberts, K J, Sa Cunha, A, Salvia, R, Strobel, O, Tarvainen, T, Bossuyt, P M, van Laarhoven, H W M, Wilmink, J W, Groot Koerkamp, B, Besselink, M G & European-African Hepato-Pancreato-Biliary Association 2020, ' Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment ', JAMA Oncology, vol. 6, no. 11, 1733-1740, pp. 1733-1740 . https://doi.org/10.1001/jamaoncol.2020.3537 JAMA oncology, 6(11), 1733-1740. American Medical Association